\contentsline {chapter}{\numberline {1}Introduction}{14}{chapter.1}%
\contentsline {chapter}{\numberline {2}Long-read Sequencing}{15}{chapter.2}%
\contentsline {section}{\numberline {2.1}Pacific Biosciences: Isoform Sequencing}{15}{section.2.1}%
\contentsline {subsection}{\numberline {2.1.1}Introduction}{15}{subsection.2.1.1}%
\contentsline {subsubsection}{\numberline {2.1.1.1}Mechanism}{17}{subsubsection.2.1.1.1}%
\contentsline {subsubsection}{\numberline {2.1.1.2}Performance and Run Quality Metric}{18}{subsubsection.2.1.1.2}%
\contentsline {subsection}{\numberline {2.1.2}Lab Pipeline}{19}{subsection.2.1.2}%
\etoc@startlocaltoc {2}
\contentsline {subsubsection}{\numberline {2.1.2.1}Complementary DNA synthesis}{22}{subsubsection.2.1.2.1}%
\contentsline {subsubsection}{\numberline {2.1.2.2}PCR optimisation and DNA Amplification}{24}{subsubsection.2.1.2.2}%
\contentsline {subsubsection}{\numberline {2.1.2.3}Polymerase Chain Reaction (PCR)}{24}{subsubsection.2.1.2.3}%
\contentsline {subsubsection}{\numberline {2.1.2.4}Agarose Gel Electrophoresis}{24}{subsubsection.2.1.2.4}%
\contentsline {subsubsection}{\numberline {2.1.2.5}AMPure Bead Purification}{25}{subsubsection.2.1.2.5}%
\contentsline {subsubsection}{\numberline {2.1.2.6}Bioanalyzer}{25}{subsubsection.2.1.2.6}%
\contentsline {subsubsection}{\numberline {2.1.2.7}Qubit}{27}{subsubsection.2.1.2.7}%
\contentsline {subsubsection}{\numberline {2.1.2.8}Target Capture using IDT Probes}{27}{subsubsection.2.1.2.8}%
\contentsline {subsubsection}{\numberline {2.1.2.9}SMRT Bell Template Preparation}{28}{subsubsection.2.1.2.9}%
\contentsline {subsubsection}{\numberline {2.1.2.10}Primer Annealing and Polymerase Binding}{28}{subsubsection.2.1.2.10}%
\contentsline {subsubsection}{\numberline {2.1.2.11}Sequencing}{29}{subsubsection.2.1.2.11}%
\contentsline {subsection}{\numberline {2.1.3}Bioinformatics Pipeline}{30}{subsection.2.1.3}%
\etoc@startlocaltoc {3}
\contentsline {subsubsection}{\numberline {2.1.3.1}Introduction}{30}{subsubsection.2.1.3.1}%
\contentsline {subsubsection}{\numberline {2.1.3.2}ERCC}{32}{subsubsection.2.1.3.2}%
\contentsline {subsubsection}{\numberline {2.1.3.3}Classify}{32}{subsubsection.2.1.3.3}%
\contentsline {subsubsection}{\numberline {2.1.3.4}Cluster}{33}{subsubsection.2.1.3.4}%
\contentsline {subsubsection}{\numberline {2.1.3.5}Genome/Transcriptome Alignment}{35}{subsubsection.2.1.3.5}%
\contentsline {subsubsection}{\numberline {2.1.3.6}Genome Mapping}{35}{subsubsection.2.1.3.6}%
\contentsline {subsubsection}{\numberline {2.1.3.7}Cupcake}{36}{subsubsection.2.1.3.7}%
\contentsline {subsubsection}{\numberline {2.1.3.8}Validation of isoforms with RNASeq}{36}{subsubsection.2.1.3.8}%
\contentsline {subsubsection}{\numberline {2.1.3.9}SQANTI2 classification and filtering of isoforms}{36}{subsubsection.2.1.3.9}%
\contentsline {subsubsection}{\numberline {2.1.3.10}Isoform expression from Iso-Seq}{39}{subsubsection.2.1.3.10}%
\contentsline {subsubsection}{\numberline {2.1.3.11}Quantification of human transgene expression}{39}{subsubsection.2.1.3.11}%
\contentsline {subsubsection}{\numberline {2.1.3.12}Classification of Alternative Splicing Events}{40}{subsubsection.2.1.3.12}%
\contentsline {subsubsection}{\numberline {2.1.3.13}Limitations}{40}{subsubsection.2.1.3.13}%
\contentsline {chapter}{\numberline {3}Whole Transcriptome}{41}{chapter.3}%
\contentsline {section}{\numberline {3.1}Introduction}{41}{section.3.1}%
\contentsline {subsection}{\numberline {3.1.1}Mouse model of AD amyloidopathy: J20}{41}{subsection.3.1.1}%
\contentsline {subsection}{\numberline {3.1.2}Mouse model of AD tauopathy: rTg4510}{41}{subsection.3.1.2}%
\contentsline {section}{\numberline {3.2}Methods}{43}{section.3.2}%
\contentsline {subsection}{\numberline {3.2.1}RNA Extraction}{43}{subsection.3.2.1}%
\contentsline {subsection}{\numberline {3.2.2}RNA-Seq Library Preparation, Illumina Sequencing \& raw data processing}{43}{subsection.3.2.2}%
\contentsline {subsection}{\numberline {3.2.3}Iso-Seq Library Preparation}{43}{subsection.3.2.3}%
\contentsline {subsection}{\numberline {3.2.4}Iso-Seq Data Processing}{44}{subsection.3.2.4}%
\contentsline {section}{\numberline {3.3}Results}{48}{section.3.3}%
\contentsline {subsection}{\numberline {3.3.1}Run performance and sequencing metrics}{48}{subsection.3.3.1}%
\contentsline {subsection}{\numberline {3.3.2}Transcriptome annotation}{51}{subsection.3.3.2}%
\contentsline {subsection}{\numberline {3.3.3}Isoform diversity}{54}{subsection.3.3.3}%
\contentsline {subsection}{\numberline {3.3.4}Iso-Seq vs RNA-Seq}{57}{subsection.3.3.4}%
\contentsline {subsection}{\numberline {3.3.5}Novel isoforms}{57}{subsection.3.3.5}%
\contentsline {subsection}{\numberline {3.3.6}Intron Retention and Nonsense mediated decay}{60}{subsection.3.3.6}%
\contentsline {subsection}{\numberline {3.3.7}Fusion Genes}{61}{subsection.3.3.7}%
\contentsline {subsection}{\numberline {3.3.8}LncRNA}{61}{subsection.3.3.8}%
\contentsline {subsection}{\numberline {3.3.9}Novel Genes}{63}{subsection.3.3.9}%
\contentsline {section}{\numberline {3.4}Discussion}{65}{section.3.4}%
\contentsline {chapter}{\numberline {4}Targeted Transcriptome}{66}{chapter.4}%
\contentsline {section}{\numberline {4.1}Introduction}{66}{section.4.1}%
\contentsline {section}{\numberline {4.2}Methods}{66}{section.4.2}%
\contentsline {section}{\numberline {4.3}Results}{72}{section.4.3}%
\contentsline {subsection}{\numberline {4.3.1}Run performance and sequencing metrics}{72}{subsection.4.3.1}%
\contentsline {subsection}{\numberline {4.3.2}Transcriptome annotation}{74}{subsection.4.3.2}%
\contentsline {subsection}{\numberline {4.3.3}Comparison with whole transcriptome}{74}{subsection.4.3.3}%
\contentsline {chapter}{\numberline {5}Transcriptional differences between WT and TG mice}{79}{chapter.5}%
\contentsline {chapter}{\numberline {6}Conclusion}{80}{chapter.6}%
\contentsline {part}{\hspace {1em}Appendix}{81}{part.1}%
\etoc@settocdepth \Etoc@section@@ 
\contentsline {chapter}{\numberline {A}Iso-Seq Targeted and Whole Transcriptome Protocol}{82}{chapter.1}%
\etoc@startlocaltoc {4}
\contentsline {subsection}{\numberline {A.0.1}Requirement of Sample quality}{83}{subsection.1.0.1}%
\contentsline {subsection}{\numberline {A.0.2}General}{83}{subsection.1.0.2}%
\contentsline {subsubsection}{\numberline {A.0.2.1}Ampure Bead Purification}{83}{subsubsection.1.0.2.1}%
\contentsline {subsubsection}{\numberline {A.0.2.2}Assessment of DNA quantity using Qubit}{85}{subsubsection.1.0.2.2}%
\contentsline {subsubsection}{\numberline {A.0.2.3}Assessment of DNA library size using Tapestation or Bioanalyzer}{86}{subsubsection.1.0.2.3}%
\contentsline {subsection}{\numberline {A.0.3}First Strand Synthesis}{86}{subsection.1.0.3}%
\contentsline {subsection}{\numberline {A.0.4}PCR Cycle Optimisation}{88}{subsection.1.0.4}%
\contentsline {subsubsection}{\numberline {A.0.4.1}Running an agarose gel}{88}{subsubsection.1.0.4.1}%
\contentsline {subsection}{\numberline {A.0.5}Large-Scale PCR}{88}{subsection.1.0.5}%
\contentsline {subsection}{\numberline {A.0.6}Bead Purification of Large-Scale PCR Products}{89}{subsection.1.0.6}%
\contentsline {subsubsection}{\numberline {A.0.6.1}Fraction 1: 2nd purification}{90}{subsubsection.1.0.6.1}%
\contentsline {subsection}{\numberline {A.0.7}Pooling Fraction 1 (1X) and 2 (0.40X)}{90}{subsection.1.0.7}%
\contentsline {subsection}{\numberline {A.0.8}Target Capture using IDT probes}{90}{subsection.1.0.8}%
\contentsline {subsubsection}{\numberline {A.0.8.1}Prepare beads for Capture}{91}{subsubsection.1.0.8.1}%
\contentsline {subsubsection}{\numberline {A.0.8.2}Binding cDNA to beads}{92}{subsubsection.1.0.8.2}%
\contentsline {subsubsection}{\numberline {A.0.8.3}Perform heated washes}{93}{subsubsection.1.0.8.3}%
\contentsline {subsubsection}{\numberline {A.0.8.4}Perform room temperature washes}{93}{subsubsection.1.0.8.4}%
\contentsline {subsubsection}{\numberline {A.0.8.5}Amplification of Captured DNA Sample}{94}{subsubsection.1.0.8.5}%
\contentsline {subsection}{\numberline {A.0.9}SMRTbell Template Preparation}{95}{subsection.1.0.9}%
\contentsline {subsubsection}{\numberline {A.0.9.1}Repair DNA Damage and Ends}{95}{subsubsection.1.0.9.1}%
\contentsline {subsubsection}{\numberline {A.0.9.2}DNA Purification}{95}{subsubsection.1.0.9.2}%
\contentsline {subsubsection}{\numberline {A.0.9.3}Prepare Blunt Ligation Reaction}{96}{subsubsection.1.0.9.3}%
\contentsline {subsubsection}{\numberline {A.0.9.4}Adding Exonuclease to remove failed ligation products}{96}{subsubsection.1.0.9.4}%
\contentsline {subsubsection}{\numberline {A.0.9.5}First Purification of SMRTbell Templates}{96}{subsubsection.1.0.9.5}%
\contentsline {subsubsection}{\numberline {A.0.9.6}Second Purification of SMRTbell Templates }{96}{subsubsection.1.0.9.6}%
\contentsline {chapter}{\numberline {B}Oxford Nanopore Transcriptome Protocol}{98}{chapter.2}%
